Shu-sheng Jiao

Chongqing, 400038, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Serum Protein-Based Profiles as Novel Biomarkers for the Diagnosis of Alzheimer's Disease.

Serum Protein-Based Profiles as Novel Biomarkers for the Diagnosis of Alzheimer's Disease.

Journal: Molecular neurobiology

Published: February 21, 2017

Plasma Amyloid-Beta Levels in Patients with Different Types of Cancer.

Plasma Amyloid-Beta Levels in Patients with Different Types of Cancer.

Journal: Neurotoxicity research

Published: July 16, 2016

Intramuscular delivery of p75NTR ectodomain by an AAV vector attenuates cognitive deficits and Alzheimer's disease-like pathologies in APP/PS1 transgenic mice.

Intramuscular delivery of p75NTR ectodomain by an AAV vector attenuates cognitive deficits and Alzheimer's disease-like pathologies in APP/PS1 transgenic mice.

Journal: Journal of neurochemistry

Published: January 14, 2016

Perspectives on the Tertiary Prevention Strategy for Alzheimer's Disease.

Perspectives on the Tertiary Prevention Strategy for Alzheimer's Disease.

Journal: Current Alzheimer research

Published: November 13, 2015

Diagnostic utility of VEGF and soluble CD40L levels in serum of Alzheimer's patients.

Diagnostic utility of VEGF and soluble CD40L levels in serum of Alzheimer's patients.

Journal: Clinica chimica acta; international journal of clinical chemistry

Published: September 29, 2015

Physiological amyloid-beta clearance in the periphery and its therapeutic potential for Alzheimer's disease.

Physiological amyloid-beta clearance in the periphery and its therapeutic potential for Alzheimer's disease.

Journal: Acta neuropathologica

Published: July 31, 2015

Sex Dimorphism Profile of Alzheimer's Disease-Type Pathologies in an APP/PS1 Mouse Model.

Sex Dimorphism Profile of Alzheimer's Disease-Type Pathologies in an APP/PS1 Mouse Model.

Journal: Neurotoxicity research

Published: July 09, 2015

Serum Amyloid-Beta Levels are Increased in Patients with Chronic Obstructive Pulmonary Disease.

Serum Amyloid-Beta Levels are Increased in Patients with Chronic Obstructive Pulmonary Disease.

Journal: Neurotoxicity research

Published: May 27, 2015

An N-terminal antibody promotes the transformation of amyloid fibrils into oligomers and enhances the neurotoxicity of amyloid-beta: the dust-raising effect.

An N-terminal antibody promotes the transformation of amyloid fibrils into oligomers and enhances the neurotoxicity of amyloid-beta: the dust-raising effect.

Journal: Journal of neuroinflammation

Published: May 05, 2015

Edaravone alleviates Alzheimer's disease-type pathologies and cognitive deficits.

Edaravone alleviates Alzheimer's disease-type pathologies and cognitive deficits.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: April 08, 2015

proBDNF Attenuates Hippocampal Neurogenesis and Induces Learning and Memory Deficits in Aged Mice.

proBDNF Attenuates Hippocampal Neurogenesis and Induces Learning and Memory Deficits in Aged Mice.

Journal: Neurotoxicity research

Published: April 06, 2015

Serum amyloid-beta levels are increased in patients with obstructive sleep apnea syndrome.

Serum amyloid-beta levels are increased in patients with obstructive sleep apnea syndrome.

Journal: Scientific reports

Published: March 13, 2015

Showing 1-12 of 16

Last Updated: 09/26/2026